Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy

Research site

Poland Ul. Wybrzeze Armii Krajowej 15, 44-102 Gliwice, Poland

1 trial recruiting
Hormone receptor positive HER2 negative breast cancer · Lung neoplasm malignant
Adult patients

About Specializations

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy in Gliwice, Poland specialises in clinical trials of conditions such as Hormone receptor positive HER2 negative breast cancer, Lung neoplasm malignant, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ul. Wybrzeze Armii Krajowej 1544-102 GliwicePoland

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 2

More sites in Gliwice Poland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Hormone receptor positive HER2 negative breast cancer

Recruiting

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

Registered drugNo placebo

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Anastrozole
Sponsor:Unicancer

Contact Research Centre

Lung neoplasm malignant

Not recruiting

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Domvanalimab
Sponsor:AstraZeneca AB

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites